Disitamab Vedotin for Injection is characterized by precise targeted tumor cell killing, significant efficacy in gastric cancer and urothelial carcinoma refractory to multiple lines of treatment, and a controllable safety profile.
Authentic
Guarantee
Fast Delivery
Privacy Disitamab Vedotin for Injection (generic name: Disitamab Vedotin) is an antibody-drug conjugate (ADC) targeting HER2-expressing solid tumors (e.g., ga···【Read More】
Update: 10 Feb,2026Source: Haiou HealthViews: 73
Disitamab vedotin is a targeted drug indicated for the treatment of specific HER2-expressing solid tumors (including gastric cancer, urothelial carcin···【Read More】
Update: 10 Feb,2026Source: Haiou HealthViews: 77
The pricing of Disitamab Vedotin varies by dosage, region and hospital policies. A single vial generally costs approximately US$$2,170 to U$$2,893. Th···【Read More】
Update: 10 Feb,2026Source: Haiou HealthViews: 72
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



